Positive Study results for PT INR

29 Nov 2010

Universal Biosensors, Inc. (ASX: UBI) today announced positive results in a clinical study assessing the performance of its next major point of care technology, the PT/INR strip and meter system. The system prototype showed excellent correlation with the current market leader in the US$400m1 point of care PT/INR market which bodes well for the next phase of its development, clinical testing and ultimately commercialisation.

View the article

All News